Quick Links

 Selected Publications

Krishnan A, Nademanee A, Fung H, Angelopoulou M, Molina A, Gaal K, Dagis A, Palmer J, Alvarnas J, Slovak M, Kogut N, Popplewell L, Rodriguez R, Schriber J, Wang S, Forman S: Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation? BBMT, June 2006, V12(6): p641-647.

Stein A, O’Donnell MR, Slovak M, Snyder D, Nademanee A, Parker P, Molina A, Somlo G, Fung H, Krishnan A, Rodriguez R, Spielberger R, Wang S, Dagis A, Vora N, Arber D, Niland J, Forman SJ: Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission. J Clin Oncol, 21; 615-623, 2003.

Krishnan A, Zaia J, Forman SJ: Should HIV-positive patients with lymphoma be offered stem cell transplants? Biol Marrow Transplan, 32; 741-748, 2003.

Molina A, Zaia J, Krishnan A: Treatment of human immunodeficiency virus-related lymphoma with haematopoietic stem cell transplantation. Blood Rev, 17, 249-258, 2003.

Fung H, Cohen S, Rodriguez R, Smith D, Krishnan A, Somlo G, Sahebi F, Senitzer D, O’Donnell MR, Stein A, Snyder D, Spielberger R, Bhatia R, Falk P, Molina A, Nademanee A, Parker P, Kogut N, Popplewell L, Vora N, Margolin K, Forman SJ: Reduced intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed. Biol Blood Marrow Transplant, 9; 649-656, 2003.

Fung H, Stein A, Slovak M, O’Donnell M, Snyder D, Cohen S, Smith D, Krishnan A, Spielberger R, Bhatia R, Bhatia S, Falk P, Molina A, Nademanee A, Parker P, Rodriguez R, Rosenthal J, Sweetman R, Kogut N, Sahebi F, Popplewell L, Vora N, Somlo G, Margolin K, Chow W, Smith E, Forman SJ: A long term follow up report of allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome. Biol Blood Marrow Transplant, 9; 766-771, 2003.

Krishnan A, Zaia J, Molina A: Stem Cell Transplantation and Gene Therapy for HIV Associated Lymphomas. J Hem Stem Cell Res, 11; 765-775, 2002.

Krishnan A, Molina A, Forman SJ: Organ Transplantation in HIV-Infected Patients. New Eng J Med, 347 1801-3, 2002.

Bhatia S, Louie AD, Bhatia R, O’Donnell MR, Fung H, Kashyap A, Krishnan A, Molina A, Nademanee A, Niland JC, Parker P, Snyder DS, Spielberger R, Stein A, Forman SJ: Solid Cancers after Bone Marrow Transplantation. J Clin Oncol, 19: 464-471, 2001.

Levine AM, Scadden DT, Zaia JA, Krishnan A: Hematologic Aspects of HIV/AIDS. Hematology. Amer Soc Hematol Educ Prog, 463-478, 2001.

Krishnan A, Molina A, Zaia J, Nademanee A, Kogut N, Rosenthal J, Woo D, Forman SJ: Autologous Stem Cell Transplantation for HIV-Lymphoma. Blood, 98: 3857-3859, 2001.

Kashyap A, Kandeel F, Yamauchi D, Palmer JM, Niland JC, Molina A, Fung H, Bhatia R, Krishnan A, Nademenee A, O’Donnell MR, Parker P, Rodriguez R, Snyder D, Spielberger R, Stein A, Nadler J, Forman SJ: Effects of Allogeneic Bone Marrow Transplantation on Recipient Bone Mineral Density: A Prospective Study. Biol Blood Marrow Transplant, 6: 344-351, 2000.

Chao NJ, Snyder D, Jain M, Wong R, Niland J, Negrin RS, Long GD, Hu WW, Goldstein K, Johnson L, Amylon M, Tierney DK, O’Donnell MR, Nademanee A, Parker P, Stein A, Molina A, Fung H, Kashyap A, Spielberger R, Krishnan A, Rodriguez R, Forman SJ, Blume KG: Equivalence of Two Effective GVHD Prophylaxis Regimens: Results of a Prospective Blinded Randomized Trial. Biol Blood Marrow Transplantation 6:254-261, 2000.

Nademanee A, Molina A, Dagis A, Snyder DS, O’Donnell MR, Parker P, Stein A, Smith E, Planas I, Kashyap A, Spielberger R, Fung H, Krishnan A, Bhatia R, Wong KK, Somlo G, Margolin K, Chow W, Sniecinski I, Vora N, Slovak M, Niland JC, Forman SJ: Autologous Stem Cell Transplantation for Poor-Risk and Relapsed Intermediate and High Grade non-Hodgkin’s Lymphoma. Clin Lymphoma, 1: 46-54, 2000.

Molina A, Krishnan A, Zaia J, Zabner R, Forman SJ: High Dose Therapy and Autologous Stem Cell Transplantation for Human Immunodeficiency Virus-Associated non-Hodgkin’s Lymphoma in the Era of Highly Active Antiretroviral Therapy (HAART) Cancer, 89: 680-89, 2000.

This is a partial list. Full publications list available  upon request. Information on this page may be self-reported and subject to change at any time. Last updated 07/08.

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.